These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Prophylactic electroshock at the dispensary in certain cases of manic-depressive psychoses]. DUCHENE H, PAUMELLE P. Ann Med Psychol (Paris); 1956 May; 114(5):867-70. PubMed ID: 13340367 [No Abstract] [Full Text] [Related]
6. [Analysis of diphenylhydantoin in electroshock and metrazol shock]. FROMMEL E, RADOUCO C, GOLD P. Med Hyg (Geneve); 1952 Oct 19; 10(228):426. PubMed ID: 13024360 [No Abstract] [Full Text] [Related]
14. [The use of thiobarbiturates in the post-convulsive phase of electroshock]. CORBINO D. Riv Neurol; 1955 Dec 19; 25(5):733-40. PubMed ID: 13298509 [No Abstract] [Full Text] [Related]
15. [Results of a study of the brain following shock therapy, especially electroshock]. SCHEIDEGGER S. Schweiz Z Pathol Bakteriol; 1950 Dec 19; 13(6):795-6. PubMed ID: 14828366 [No Abstract] [Full Text] [Related]
16. Discussion of non-convulsive electric shock. SAUNDERS JR, COATES TF. South Med Surg; 1950 Nov 19; 112(11):367-9. PubMed ID: 14787653 [No Abstract] [Full Text] [Related]
17. [On the potentiating effect of reserpine in electroshock and its inhibition by 1-piperidinomethyl-2-tetralone]. KNOLL J. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1960 Nov 19; 238():114-5. PubMed ID: 14410178 [No Abstract] [Full Text] [Related]
18. Socio-economic aspects of the shock therapies in schizophrenia. FELDMAN F, SUSSELMAN S, BARRERA SE. Am J Psychiatry; 1947 Dec 19; 104(6):402-9. PubMed ID: 18911625 [No Abstract] [Full Text] [Related]